UK Hospitals Missing Frailty Screening for Surgery Patients
Nearly three-quarters of UK hospitals are not routinely screening older surgical patients for frailty, despite known risks of adverse outcomes.
A study by the Royal College of Anaesthetists (RCoA) and the University of Nottingham found that 71% of hospitals do not assess frailty in patients over 60.
The research, published in the British Journal of Anaesthesia, shows that 1 in 5 surgical patients in this age group are living with frailty. This condition significantly increases the risk of complications, extended hospital stays, delirium, and death.
Largest UK Study on Frailty in Surgical Patients
The findings are from the RCoA's third Sprint National Anaesthesia Project (SNAP3), the UK's most comprehensive study on frailty and multimorbidity in surgical patients.
Researchers collected data from 7129 patients aged over 60 across 214 NHS hospitals. Data was gathered over five consecutive days in March 2022.
The observational study found that older patients living with frailty:
Stay an average of three days longer in hospital post-surgery.
Stay six days longer if they are severely frail.
Are three times more likely to experience complications.
Are four times more likely to develop post-operative delirium.
Are three times more likely to die within a year of surgery.
Lack of Awareness Among Clinicians
The researchers identified limited clinician awareness about the impact of frailty and multimorbidity on postoperative outcomes as a key barrier to improving outcomes.
The researchers recommended routine frailty assessments for all patients over 60 before surgery. This would allow for tailored care, with input from geriatricians where appropriate.
The Clinical Frailty Scale (CFS) is a ssimple assessment tool that clinicians can use to identify frailty and guide appropriate referrals, the RCoA said.
Improving Patient Recovery
Dr Claire Shannon, president of the RCoA, said universal frailty screening could significantly improve patient recovery.
'With older people accounting for an increasing proportion of surgical patients, implementing effective screening for frailty is becoming ever more necessary,' she said. 'Universal adoption of frailty assessments will not only help patients recover better from surgery but also help improve efficiency by avoiding extended lengths of stay in hospital.'
Iain Moppett, chief investigator of SNAP3 and professor at the University of Nottingham's School of Medicine, said screening supports better decision-making.
'Identifying frailty is straightforward and should lead to open and honest discussions with patients,' he said. 'Good teamwork between the right specialists — surgeons, anaesthetists, and geriatricians — helps to get patients living with frailty as fit and well as possible before surgery, make the right decisions, and get the best care after surgery.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TechCrunch
17 minutes ago
- TechCrunch
Hinge CMO Jackie Jantos hopes to help make Gen Zers less lonely
Dating apps have developed a bad reputation lately. People ghost others, which means they simply stop responding to someone they once shared frequent correspondence with. There appear to be slim pickings, despite living in big cities like New York, and did we mention a lot of these apps now cost money? At the inaugural SXSW London, TechCrunch caught up with Jackie Jantos, the CMO and president of Hinge, to talk about how the company is marketing itself to a new generation in what has become a listless dating scene. 'This is a generation that has grown up with a deep understanding of how digital experiences are created and what they are trying to get out of them,' Jantos said in an interview with TechCrunch. She listed out the traits Gen Zers want most out of their brands, like transparency and authenticity. It's a diverse generation that spends less time in person than its predecessors. 'If you're not building with inclusion at the center of everything, you're just not going to build a meaningful product or marketing activation to engage them,' she said. The dating app landscape has evolved over the past few years, seeing companies like Hinge working overtime to try and attract and sustain user attention. Tinder, for example, has struggled with growth in the past few years, culminating in the stepping down of its CEO a few weeks ago. Bumble is also seeing a slowdown in user growth. Hinge and Tinder are both owned by Match Group. The Q1'2025 report released by Match Group shows that Hinge is faring a bit better than its sister company. The report showed that Hinge saw an increase in direct revenue, compared to Tinder, and that the app's downloads were 'strong' across the English-speaking and Western European markets. Techcrunch event Save now through June 4 for TechCrunch Sessions: AI Save $300 on your ticket to TC Sessions: AI—and get 50% off a second. Hear from leaders at OpenAI, Anthropic, Khosla Ventures, and more during a full day of expert insights, hands-on workshops, and high-impact networking. These low-rate deals disappear when the doors open on June 5. Exhibit at TechCrunch Sessions: AI Secure your spot at TC Sessions: AI and show 1,200+ decision-makers what you've built — without the big spend. Available through May 9 or while tables last. Berkeley, CA | REGISTER NOW Jantos said Hinge is implementing and toying around with numerous new features at the moment. For example, it has added a quota on how many chats one person can have at one time so that a user isn't simply 'collecting chats.' 'We want to encourage people to close out chats if you're not interested in someone,' Jantos said, adding that hopefully this encourages people to focus on a smaller number of conversations that can successfully move toward a date. She said Hinge is testing its coaching feature, which looks to give users tips about building their profiles. The Match Group Q1'2025 report said Hinge was also looking to introduce Warm Introductions soon to 'highlight shared interests to improve match quality.' Jantos was coy on details but said there was a new introduction that would hopefully encourage users to 'spend a little more time discovering each profile.' 'Our recommendations have gotten really strong with the new AI recommender that we recently released,' she added. (Match Group's Q1'2025 news report said the new feature, launched in March, has already driven a 15% increase in matches and contact exchanges.) Jantos said that Hinge is also hoping to boost its safety features with AI and that overall, tools on the app will 'continuously improve because of AI.' 'But also new tools will come along the wya to coach you along the [dating] journey,' she said. Jantos flew into the inaugural SXSW London to give a talk about the loneliness epidemic impacting Gen Zers. There is no shortage of stories and reports on how young people are connecting less with the outside world, glued to their phones and virtual realities. Jantos told TechCrunch this is one reason Hinge launched its One More Hour fund in 2023. The fund seeks to invest $1 million into organizations to foster more in-person connections among Gen Zers. She's heard feedback from young people on her team that there are barriers to hanging out these days, including how expensive it's become and finding places that feel safe. 'We want to lower the barrier so people just want to come out because we know if they build that skill, it's more likely when they're on our product, they'll be more likely to be comfortable meeting someone up for a date,' she said. And, as expected, Hinge is throwing events, filling ads with creators, such as writers, to 'meet the audience where they are.' It created a Zine and campaign about Hinge success stories to hopefully inspire Gen Zers to go find love. And even better, on the Hinge app.
Forbes
37 minutes ago
- Forbes
Gene Therapy For Inherited Disease In The Unborn Child
Until recently, even the most advanced gene therapies could only be given after a child was ... More born—often racing against time to prevent irreversible damage. In the first part of this series, we explored how early genetic screening and gene therapy transform the lives of newborns and their families. Now, we're taking an even earlier step: treating inherited diseases in the womb before birth. Until recently, even the most advanced gene therapies could only be given after a child was born—often racing against time to prevent irreversible damage. But what if we could intervene even earlier? That's the question now being answered, with some astonishing results. A recent study published in Science Translational Medicine showed that delivering a special kind of genetic therapy directly to the fetus could prevent the onset of spinal muscular atrophy in animal models. Treating the condition before birth may be possible to preserve healthy motor function and prevent the nerve damage that usually begins in the womb. This is the first time we see molecular therapies targeting the root cause of inherited disease before birth. Another special investigational case, the first in humans, found that providing the mother with gene therapy while pregnant and continuing treatment after birth also prevented the devastating muscle weakness that usually comes with the disease. This is a true leap forward: instead of managing symptoms; we may soon be able to stop some inherited diseases before they ever begin. The journey starts with advanced prenatal genetic screening. Genetic changes in the developing fetus can be found using a simple blood sample from the mother. When a risk is found, therapy is delivered directly to the fetus, often by injecting medicine into the amniotic fluid. In the case of spinal muscular atrophy, this approach in animal models led to healthier development and longer survival. These findings suggest that intervening before birth can prevent or significantly reduce the neurological damage that begins in the womb and progresses rapidly after birth. While most of this research has been in animals, the first human steps have already begun. In February 2025, the University of California, San Francisco, reported the world's first attempt to treat a genetic disease in a human fetus using a medication called risdiplam. After learning that her unborn child was at risk, a mother began taking the medication late in pregnancy. The baby was born healthy and—now more than two years old—shows no signs of the disease, though some developmental challenges remain. Another important step was taken in a clinical trial at UCSF, where doctors successfully treated a fetus with a different rare disease using enzyme replacement therapy, showing that the technology for delivering medicine to the unborn is already here. Many inherited diseases cause the most significant harm before a baby is even born. By intervening early, we have the chance to save lives and give children the best possible start—preserving their ability to move, think, and grow. This isn't just a medical advance. It's a new way of thinking about what's possible for families facing genetic disease. Of course, there are still challenges ahead. Many are working to ensure these therapies are safe, effective, and accessible to all who need them. Ethical questions about when and how to use these powerful tools will also need careful thought. The first human applications of gene therapy before birth are expected within the next decade, pending rigorous safety and ethical evaluations. This new era also brings new questions. If we correct a genetic error in a child before birth, will that change be passed on to future generations? For now, most therapies target the body's somatic cells, not the germline, so the changes are not inherited. However, the line between somatic and germline interventions may blur as technology evolves, raising complex ethical considerations. The first human trials of in-utero gene therapy are just beginning, and more research is needed. But the direction is clear: as technology advances, we are moving from treating inherited diseases after birth to preventing them at the start of life. As I have often said, the future of medicine is being rewritten, one gene at a time. This latest breakthrough brings us one step closer to a world where prevention, rather than treatment, becomes the standard for genetic disease, where every child can live their healthiest life from the very start. As discussed in my book, the hope is that every child will soon have the chance to live their healthiest life from the beginning.
Yahoo
an hour ago
- Yahoo
Debt and trade issues weaken UK growth, OECD says
UK economic growth will suffer because of US tariff barriers and high interest payments on government debt, an influential global policy group has said. The Organization for Economic Co-operation and Development (OECD) cut its expectations for UK growth this year to 1.3% from the 1.4% it had predicted in March. The think tank has cut forecasts globally due to trade tensions, but said the UK faced particular issues due to its "very thin" buffer in public finances, calling on Chancellor Rachel Reeves to boost tax take and cut spending. "Strengthening the public finances remains a priority... including through the upcoming Spending Review," the OECD said. Next week, Reeves will set out her Spending Review where she faces tough choices on allocating departmental budgets. The government has already committed billions of pounds to defence, while the NHS is also expected to be a focus amid Labour's pledge to reduce waiting lists. In March, Reeves was forced to announce £14bn in measures, including £4.8bn in welfare cuts, to restore headroom against her self-imposed fiscal rules. While the OECD highlighted better-than-expected UK economic growth, which strengthened to 0.7% between January and March, it cautioned that "momentum is weakening" due to "deteriorating" business sentiment. It forecast the UK economy would expand by 1% in 2026, compared to the 1.2% it pencilled in a few months ago. "The state of the public finances is a significant downside risk to the outlook if the fiscal rules are to be met," the OECD said. It suggested that Reeves should adopt a "balanced approach" of "targeted spending cuts" and tax increases to improve the UK's public finances. It suggested closing tax loopholes and re-evaluating council tax bands based on updated property values. Under the current system, council tax in England is calculated based on the price the property would have sold for in April 1991. For Wales, it is evaluated on property prices in April 2003. Meanwhile, worldwide growth is now expected to slow to a "modest" 2.9%, down from a previous forecast of 3.1%, the OECD said. It blamed a "significant" rise in trade barriers and warned that "weakened economic prospects will be felt around the world, with almost no exception". The OECD's comments come as Bank of England governor Andrew Bailey told a Treasury Select Committee on Wednesday that the global system of trade agreements had been "blown up to a considerable degree" by global trade tensions. Since US President Donald Trump returned to the White House, a long list of countries have been targeted by tariffs, but Trump's unpredictable approach to implementing the measures has created widespread uncertainty. "We are forecasting basically a downgrade for almost everybody," Alvaro Pereira, the OECD's chief economist told the BBC. "We'll have a lot less growth and job creation than we had forecasted in the past." The group also slashed the outlook for the US economy this year from 2.2% to 1.6% and predicted growth would slow again in 2026. It warned that the US was at risk from rising inflation, something that Trump repeatedly promised would fall during his presidential campaign. Prior to the release of the OECD report on Tuesday, Trump wrote on social media: "Because of Tariffs, our Economy is BOOMING!" However, the most recent official data showed the US economy shrank at an annual rate of 0.2% in the first three months of this year, the first contraction since 2022. What tariffs has Trump announced and why? US to double tariffs on steel and aluminium imports to 50%, Trump says China says US has 'severely violated' tariffs truce
